Travere Therapeutics, Inc. Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Travere Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • Travere Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $2.8M, a 3.45% decline year-over-year.
  • Travere Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $11.2M, a 1.75% decline year-over-year.
  • Travere Therapeutics, Inc. annual Interest Expense for 2023 was $11.3M, a 2.73% increase from 2022.
  • Travere Therapeutics, Inc. annual Interest Expense for 2022 was $11M, a 44.2% decline from 2021.
  • Travere Therapeutics, Inc. annual Interest Expense for 2021 was $19.7M, a 3.14% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.3M +$300K +2.73% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $11M -$8.7M -44.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $19.7M +$600K +3.14% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $19.1M +$300K +1.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $18.8M +$8.99M +91.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $9.81M +$5.39M +122% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $4.42M -$312K -6.59% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $4.73M -$2.97M -38.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $7.7M +$300K +4.05% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
2014 $7.4M +$7.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $0 -$84.1K -100% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $84.1K Jan 1, 2012 Dec 31, 2012 10-K/A 2015-07-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.